© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Arbidol Hydrochloride, recognized by its unique molecular formula C22H26BrN3O3S·HCl and molecular weight of 513.89 g/mol, belongs to the group of synthetic antiviral compounds. It gained substantial attention throughout the past several decades, especially during respiratory virus outbreaks. The material exists as a raw intermediate within pharmaceutical manufacturing, serving as the foundation for final antiviral products prescribed in many countries. My observations in the pharmacological field reveal most chemical suppliers and formulators prioritize materials like this as a backbone ingredient due to their extensive usage and precise characterization in treatment regimens. As a seasoned professional, I have seen firsthand the demand sway depending on viral outbreaks, sharply increasing during flu seasons and global pandemics.
Arbidol Hydrochloride is commonly encountered as an odorless, off-white to pale yellow crystalline powder. Its structure features a distinctive indole core linked to a bromophenyl group, which ties closely to its antiviral effects. Production batches range in appearance—some display fine powder, others take on larger, flaky, or even pearlescent crystals, based on synthesis and purification steps involved. The density consistently hovers around 1.6 g/cm³ at ambient temperature. The compound’s melting point lands near 174-177°C, conveying its thermal stability during shipping and storage. Suppliers sell it as a solid bulk raw material. Solubility varies—readily dissolves in dimethyl sulfoxide, ethanol, and methanol, but shows limited solubility in water, a trait that matters when integrating the compound into oral doses and injectable forms. Most chemical handlers and pharmacists manage it as a dry solid to ensure consistent dosing and easy measurement during compounding.
Throughout my years working alongside research chemists, the relevance of clear, accurate chemical identification remains apparent. The molecular formula, C22H26BrN3O3S·HCl, paired with a sharply defined crystal structure, allows specialists to authenticate product batches and uphold rigorous quality controls. In large-scale synthesis, Arbidol Hydrochloride dissolves into specific non-aqueous solvents to form stock solutions used in preclinical research or drug formulation. As a solution, it retains stability under typical light and temperature conditions. In the raw state, it appears as a neat, crystalline material, which assists in visual quality checks before measuring, milling, or further processing. The raw ingredient serves as a traceable benchmark for batch consistency, providing a dependable reference point for pharmaceutical scientists, manufacturing technicians, and safety officers.
Manufacturers and distributors pay close attention to safety handling, influenced by the documented hazardous properties of Arbidol Hydrochloride. Material safety data sheets cite harmful effects if consumed in large amounts or through improper exposure. The compound can cause skin and eye irritation, and inhalation risks increase during handling of fine powders, a familiar concern in the chemical sector. Technicians working with the substance rely on gloves, breathing masks, and fume hoods to protect against accidental inhalation or contact. Despite its role in public health, the active ingredient demands solid safety practices at all levels, from chemical synthesis through to packaging and shipping. Regulatory requirements obligate clear hazard communication, and my own audits showed that rigor in chemical storage, labeling, and documentation avoided workplace incidents and ensured compliance with international chemical handling rules.
For seamless logistics and trade, Arbidol Hydrochloride falls under HS Code 2934999099, classifying it as an organic chemical product not elsewhere specified. This code streamlines import, export, and customs declarations for global shipments. Recognized specifications—including assay, loss on drying, residue on ignition, and impurity profile—anchor acceptance standards for pharmaceutical manufacturers. The content needs to meet strict purity thresholds, generally 98% and above, set by pharmacopeial compendia and drug regulatory authorities. The push for enhanced safety, traceability, and ethical sourcing stands out as a result of rising regulatory scrutiny. I have dealt with customs inspections on biotech imports where providing the unique HS Code and detailed certificate of analysis made the difference between seamless release and costly delays.
Within the pharmaceutical sector, Arbidol Hydrochloride operates as a cornerstone chemical for the production of antiviral medications. Its reliability as a raw material means manufacturers can produce millions of oral tablets, capsules, and liquid suspensions. The robust crystalline form ensures ease of blending and compounding in automated production lines. It supports formulation work for both adult and pediatric drug products, a versatility my colleagues in product development have valued in advancing new antiviral therapies. Any deviation in quality, whether from substandard raw ingredients or inconsistent density, leads to batch failures, cost overruns, or product recalls. The significance of trustworthy suppliers echoes through the entire drug development cycle, impacting everyone from R&D scientists to frontline clinicians.
Challenges persist in sourcing and verifying high-purity Arbidol Hydrochloride, especially when global demand surges or supply chains strain under logistical hurdles. Counterfeit or adulterated batches still appear in poorly regulated markets. Building transparent relationships with reputable suppliers who meet international GMP standards forms a foundational solution to safeguard quality. Improving analytical techniques—like chromatographic fingerprinting and high-resolution NMR—gives additional assurance for raw material authentication. Open sharing of supply chain data and pooled procurement systems might lessen shortages in times of crisis. Investment in advanced protective equipment and on-site environmental controls keeps both workers and end-users out of harm’s way. My experience in laboratory management confirms that maintaining rigorous, standardized operating procedures and regular staff training eliminates many preventable problems tied to hazardous chemical handling, helping deliver safe, effective antiviral treatments to those who need them the most.
